 | • レポートコード：QFJ1-5715 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、DNAジャイレースサブユニットBの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（GYR-12、DS-2969、VXC-100、VT-12008911、その他）、用途別市場規模（細菌感染症、クロストリジウム・ディフリエ感染症、クレブシエラ・ニューモニアエ感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・DNAジャイレースサブユニットBの市場動向 ・企業の競争状況、市場シェア ・DNAジャイレースサブユニットBの種類別市場規模と予測2016-2027（GYR-12、DS-2969、VXC-100、VT-12008911、その他） ・DNAジャイレースサブユニットBの用途別市場規模と予測2016-2027（細菌感染症、クロストリジウム・ディフリエ感染症、クレブシエラ・ニューモニアエ感染症、その他） ・DNAジャイレースサブユニットBの北米市場規模2016-2027（アメリカ、カナダ） ・DNAジャイレースサブユニットBの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・DNAジャイレースサブユニットBのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・DNAジャイレースサブユニットBの中南米市場規模2016-2027（メキシコ、ブラジル） ・DNAジャイレースサブユニットBの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abgentis Limited、AstraZeneca Plc、Daiichi Sankyo Company Ltd、Merck & Co., Inc.） ・結論 |
Market Analysis and Insights: Global DNA Gyrase Subunit B (EC 5.99.1.3) Market
The global DNA Gyrase Subunit B (EC 5.99.1.3) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DNA Gyrase Subunit B (EC 5.99.1.3) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DNA Gyrase Subunit B (EC 5.99.1.3) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DNA Gyrase Subunit B (EC 5.99.1.3) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DNA Gyrase Subunit B (EC 5.99.1.3) market.
Global DNA Gyrase Subunit B (EC 5.99.1.3) Scope and Market Size
DNA Gyrase Subunit B (EC 5.99.1.3) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DNA Gyrase Subunit B (EC 5.99.1.3) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
GYR-12
DS-2969
VXC-100
VT-12008911
Others
Segment by Application
Bacterial Infections
Clostridium Diffclie Infections
Klebsiella Pneumoniae Infections
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abgentis Limited
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Merck & Co., Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 GYR-12
1.2.3 DS-2969
1.2.4 VXC-100
1.2.5 VT-12008911
1.2.6 Others
1.3 Market by Application
1.3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bacterial Infections
1.3.3 Clostridium Diffclie Infections
1.3.4 Klebsiella Pneumoniae Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Perspective (2016-2027)
2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Growth Trends by Regions
2.2.1 DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Share by Regions (2016-2021)
2.2.3 DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Regions (2022-2027)
2.3 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Dynamic
2.3.1 DNA Gyrase Subunit B (EC 5.99.1.3) Market Trends
2.3.2 DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
2.3.3 DNA Gyrase Subunit B (EC 5.99.1.3) Market Challenges
2.3.4 DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Revenue
3.1.1 Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Revenue (2016-2021)
3.1.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Players (2016-2021)
3.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue
3.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Concentration Ratio
3.4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue in 2020
3.5 DNA Gyrase Subunit B (EC 5.99.1.3) Key Players Head office and Area Served
3.6 Key Players DNA Gyrase Subunit B (EC 5.99.1.3) Product Solution and Service
3.7 Date of Enter into DNA Gyrase Subunit B (EC 5.99.1.3) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Gyrase Subunit B (EC 5.99.1.3) Breakdown Data by Type
4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size by Type (2016-2021)
4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Type (2022-2027)
5 DNA Gyrase Subunit B (EC 5.99.1.3) Breakdown Data by Application
5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Historic Market Size by Application (2016-2021)
5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2016-2027)
6.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
6.2.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021)
6.2.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027)
6.2.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2027)
6.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
6.3.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021)
6.3.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027)
6.3.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2027)
6.4 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
6.4.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021)
6.4.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2016-2027)
7.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
7.2.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021)
7.2.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027)
7.2.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2027)
7.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
7.3.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021)
7.3.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027)
7.3.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2027)
7.4 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
7.4.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021)
7.4.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2016-2027)
8.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
8.2.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2027)
8.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
8.3.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2027)
8.4 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region
8.4.1 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2016-2027)
9.2 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
9.2.1 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021)
9.2.2 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027)
9.2.3 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2027)
9.3 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
9.3.1 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021)
9.3.2 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027)
9.3.3 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2027)
9.4 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
9.4.1 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021)
9.4.2 Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2016-2027)
10.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
10.2.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2027)
10.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
10.3.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2027)
10.4 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
10.4.1 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abgentis Limited
11.1.1 Abgentis Limited Company Details
11.1.2 Abgentis Limited Business Overview
11.1.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
11.1.4 Abgentis Limited Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
11.1.5 Abgentis Limited Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
11.2.4 AstraZeneca Plc Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
11.2.5 AstraZeneca Plc Recent Development
11.3 Daiichi Sankyo Company Ltd
11.3.1 Daiichi Sankyo Company Ltd Company Details
11.3.2 Daiichi Sankyo Company Ltd Business Overview
11.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
11.3.4 Daiichi Sankyo Company Ltd Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
11.3.5 Daiichi Sankyo Company Ltd Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Introduction
11.4.4 Merck & Co., Inc. Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
11.4.5 Merck & Co., Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of GYR-12
Table 3. Key Players of DS-2969
Table 4. Key Players of VXC-100
Table 5. Key Players of VT-12008911
Table 6. Key Players of Others
Table 7. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Regions (2016-2021)
Table 11. Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Regions (2022-2027)
Table 13. DNA Gyrase Subunit B (EC 5.99.1.3) Market Trends
Table 14. DNA Gyrase Subunit B (EC 5.99.1.3) Market Drivers
Table 15. DNA Gyrase Subunit B (EC 5.99.1.3) Market Challenges
Table 16. DNA Gyrase Subunit B (EC 5.99.1.3) Market Restraints
Table 17. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Players (2016-2021)
Table 19. Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) as of 2020)
Table 20. Ranking of Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players DNA Gyrase Subunit B (EC 5.99.1.3) Product Solution and Service
Table 24. Date of Enter into DNA Gyrase Subunit B (EC 5.99.1.3) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021) (US$ Million)
Table 27. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2016-2021)
Table 28. Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2016-2021)
Table 32. Global DNA Gyrase Subunit B (EC 5.99.1.3) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021) (US$ Million)
Table 35. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021) (US$ Million)
Table 37. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abgentis Limited Company Details
Table 65. Abgentis Limited Business Overview
Table 66. Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product
Table 67. Abgentis Limited Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021) & (US$ Million)
Table 68. Abgentis Limited Recent Development
Table 69. AstraZeneca Plc Company Details
Table 70. AstraZeneca Plc Business Overview
Table 71. AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product
Table 72. AstraZeneca Plc Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021) & (US$ Million)
Table 73. AstraZeneca Plc Recent Development
Table 74. Daiichi Sankyo Company Ltd Company Details
Table 75. Daiichi Sankyo Company Ltd Business Overview
Table 76. Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product
Table 77. Daiichi Sankyo Company Ltd Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021) & (US$ Million)
Table 78. Daiichi Sankyo Company Ltd Recent Development
Table 79. Merck & Co., Inc. Company Details
Table 80. Merck & Co., Inc. Business Overview
Table 81. Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product
Table 82. Merck & Co., Inc. Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021) & (US$ Million)
Table 83. Merck & Co., Inc. Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type: 2020 VS 2027
Figure 2. GYR-12 Features
Figure 3. DS-2969 Features
Figure 4. VXC-100 Features
Figure 5. VT-12008911 Features
Figure 6. Others Features
Figure 7. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application: 2020 VS 2027
Figure 8. Bacterial Infections Case Studies
Figure 9. Clostridium Diffclie Infections Case Studies
Figure 10. Klebsiella Pneumoniae Infections Case Studies
Figure 11. Others Case Studies
Figure 12. DNA Gyrase Subunit B (EC 5.99.1.3) Report Years Considered
Figure 13. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Regions: 2020 VS 2027
Figure 16. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Regions (2022-2027)
Figure 17. Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Players in 2020
Figure 18. Global Top DNA Gyrase Subunit B (EC 5.99.1.3) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Gyrase Subunit B (EC 5.99.1.3) as of 2020
Figure 19. The Top 10 and 5 Players Market Share by DNA Gyrase Subunit B (EC 5.99.1.3) Revenue in 2020
Figure 20. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2016-2021)
Figure 21. Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue Market Share by Type (2022-2027)
Figure 22. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2016-2027)
Figure 24. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2016-2027)
Figure 25. North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2016-2027)
Figure 26. United States DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2016-2027)
Figure 30. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2016-2027)
Figure 31. Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2016-2027)
Figure 32. Germany DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2016-2027)
Figure 40. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2016-2027)
Figure 41. Asia-Pacific DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Region (2016-2027)
Figure 42. China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2016-2027)
Figure 50. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2016-2027)
Figure 51. Latin America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2016-2027)
Figure 52. Mexico DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2016-2027)
Figure 56. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2016-2027)
Figure 57. Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2016-2027)
Figure 58. Turkey DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE DNA Gyrase Subunit B (EC 5.99.1.3) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abgentis Limited Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
Figure 62. AstraZeneca Plc Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
Figure 63. Daiichi Sankyo Company Ltd Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in DNA Gyrase Subunit B (EC 5.99.1.3) Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年） Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in…- 世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年） According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic …
- 世界の人工関節感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界の周産期感染症治療市場規模・現状・予測（2021年-2027年） Perinatal infections include bacterial or viral illnesses that can be passed from a mother to her baby either while the baby is still in the uterus or during the delivery process. Maternal infection can, in some cases, cause complications at birth. Market Analysis and Insights: Global Perinatal Infe…
- 世界の後天性感染症検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Acquired Infections Testing Market The global Acquired Infections Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…